We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Pharmaceutical drug development and commercial manufacturing is complex and risky. Packaging and drug delivery add challenges. With West by your side, you can find solutions to industry challenges such as:
In parenteral drug development, packaging is often discussed as a format decision based on containment in vials, prefillable syringes, or cartridges. In reality, packaging choices involve far more than the container itself. Packaging influences product stability, manufacturing complexity, patient experience, and long-term lifecycle performance.
For teams entering the parenteral packaging space, the goal should not be to simply identify a “best” option. However, the goal should be to select the format that best aligns with the drug product’s characteristics, the intended patient population, and the development strategy.
Continuing our commitment to strengthening the communities where we live and work, the Bangalore GTC team recently completed another successful technology donation drive, providing refurbished laptops and other devices to schools with limited access to technology. This initiative reflects our dedication to sustainable development and demonstrates how our people can use what they do best to make a meaningful difference in empowering future generations.
Controlling particulate matter in injectable drug products has long been a cornerstone of patient safety. While large visible particles often gain public attention through recalls, subvisible particulate contamination the particles you can’t see pose an equally serious risk. These particles can compromise product quality, trigger inflammation or immune reactions, and jeopardize the safety of sensitive patient populations.
In parenteral drug development, packaging is often discussed as a format decision based on containment in vials, prefillable syringes, or cartridges. In reality, packaging choices involve far more than the container itself. Packaging influences product stability, manufacturing complexity, patient experience, and long-term lifecycle performance.
For teams entering the parenteral packaging space, the goal should not be to simply identify a “best” option. However, the goal should be to select the format that best aligns with the drug product’s characteristics, the intended patient population, and the development strategy.
Continuing our commitment to strengthening the communities where we live and work, the Bangalore GTC team recently completed another successful technology donation drive, providing refurbished laptops and other devices to schools with limited access to technology. This initiative reflects our dedication to sustainable development and demonstrates how our people can use what they do best to make a meaningful difference in empowering future generations.
Controlling particulate matter in injectable drug products has long been a cornerstone of patient safety. While large visible particles often gain public attention through recalls, subvisible particulate contamination the particles you can’t see pose an equally serious risk. These particles can compromise product quality, trigger inflammation or immune reactions, and jeopardize the safety of sensitive patient populations.
English
Chinese
